CARE revises Panacea Biotec‘s long term bank facilities to ‘BB’

08 Aug 2012 Evaluate

Credit rating agency, Credit Analysis & Research (CARE) has revised credit rating pertaining to long term bank facilities of Panacea Biotec to ‘BB’ from ‘A-‘.  ‘CARE BB’ rating is applicable to instruments which are considered to have moderate risk of default regarding timely servicing of financial obligations.

The rating agency has also revised the short term bank facilities of the company to ‘A4’ from ‘A2+’. ‘CARE A4’ rating is applicable to instruments having tenure up to one year and are considered to have minimal degree of safety regarding timely payment of financial obligations. Such instruments carry very high credit risk and are susceptible to default.

Panacea Biotec is one of India’s leading research based health management companies with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

407.05 48.55 (13.54%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×